Technology
Health
Pharmaceutical

Gamida Cel

$7.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.33 (-4.42%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Gamida Cel and other stocks, options, ETFs, and crypto commission-free!

About

Gamida Cell Ltd. Ordinary Shares, also called Gamida Cel, is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Read More Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.

Employees
73
Headquarters
Jerusalem, Jerusalem
Founded
1998
Market Cap
187.80M
Price-Earnings Ratio
Dividend Yield
Average Volume
30.89K
High Today
$7.20
Low Today
$7.00
Open Price
$7.20
Volume
4.44K
52 Week High
$15.41
52 Week Low
$6.65

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Cancer Prevention
2018 IPO
Asia (Non-China)

News

Yahoo FinanceMay 9

Gamida Cell to Participate in Two Upcoming Healthcare Conferences in New York City

BOSTON--(BUSINESS WIRE)-- Gamida Cell Ltd. (GMDA), a leading cellular and immune therapeutics company, today announced that the company will participate in two upcoming healthcare conferences taking place in New York City during May. On Thursday, May 16, 2019, members of Gamida Cell’s management team will participate in investor meetings at the Oppenheimer & Co. Oncology Insight Summit. Additionally, Julian Adams, Ph.D., chief executive officer of Gamida Cell, will participate in a “fireside chat” at the...

14
Yahoo FinanceApr 30

Gamida Cell Announces the Date of Its First Quarter 2019 Financial Results and Webcast

BOSTON--(BUSINESS WIRE)-- Gamida Cell Ltd. (GMDA), a leading cellular and immune therapeutics company, today announced that the company will host a conference call and live audio webcast on Tuesday, May 7, 2019, at 8:30 a.m. ET to review its first quarter 2019 financial results and provide an update on the company. A live webcast of the conference call can be accessed in the “Investors” section of Gamida Cell’s website at www.gamida-cell.com. To participate in the live call, please dial 866-930-5560 (dome...

39

Earnings

-$32.79
-$21.98
-$11.18
-$0.37
Q4 2018
Q1 2019
Estimated
-$0.37 per share
Actual
-$0.62 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.